Cargando…
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remai...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273631/ https://www.ncbi.nlm.nih.gov/pubmed/35837537 http://dx.doi.org/10.2147/IDR.S364525 |
_version_ | 1784745118433017856 |
---|---|
author | Zhang, Meng Wang, Zhao Wang, Jiaxi Lv, Hairong Xiao, Xia Lu, Wenyi Jin, Xin Meng, Juanxia Pu, Yedi Zhao, MingFeng |
author_facet | Zhang, Meng Wang, Zhao Wang, Jiaxi Lv, Hairong Xiao, Xia Lu, Wenyi Jin, Xin Meng, Juanxia Pu, Yedi Zhao, MingFeng |
author_sort | Zhang, Meng |
collection | PubMed |
description | BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remains to be studied, especially after empiric antibiotic treatment. METHODS: We retrospectively analyzed the differences between mNGS and the traditional methods in 192 patients with hematological malignancies who have received empiric antibiotic treatment. Samples were collected when patient had chills or half an hour before peak body temperature. And we compared the differences between FN and non-FN patients, mainly including types of pathogens and the diagnostic value of different pathogens. RESULTS: Despite receiving empirical treatment, the pathogen detection rate of mNGS was significantly higher than the traditional method (80.21% vs 25.00%, P<0.001). And it has obvious advantages in detecting mixed pathogens infection (80.21% vs 4.17%, P<0.001). Then, we found that mNGS saw more pathogens in the FN than in the non-FN group, especially fungus. 21/33 (63.63%) of FN patients was diagnosed with fungal infections. The fungal detection rate in FN was significantly higher than non-FN group (32.35% vs 12.22%, P=0.001). Besides, the sensitivity of mNGS was higher than the traditional methods in both FN and non-FN group (P<0.001), but no significant difference in specificity (P>0.05). In the FN group, empiric antibiotic treatment of 46/102 (45.10%) patients did not treat all the pathogens detected by mNGS. After adjusting the antimicrobial regimen according to the results of mNGS, the effective rate at 72 hours and 7 days was 22/46 (47.83%) and 24/102 (52.17%), respectively. CONCLUSION: mNGS had a significant impact on the diagnosis of infection and the second-line antimicrobial therapy in FN. mNGS plays a more important role in FN patients, especially in the diagnosis of fungal infections. PURPOSE: Firstly, we compared the difference between mNGS and the traditional methods in the diagnosis of infection. Secondly, we assessed the value of mNGS in FN patients by comparing it with non-FN patients, including types of pathogens and the diagnostic value of different pathogens. In order to show that mNGS plays a more important role in FN. |
format | Online Article Text |
id | pubmed-9273631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92736312022-07-13 The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure Zhang, Meng Wang, Zhao Wang, Jiaxi Lv, Hairong Xiao, Xia Lu, Wenyi Jin, Xin Meng, Juanxia Pu, Yedi Zhao, MingFeng Infect Drug Resist Original Research BACKGROUND: It was crucial to use empirical antibiotics in febrile neutropenia (FN) patients. However, most patients still died from infection due to poor efficacy. Metagenomic next-generation sequencing (mNGS) is a rapid microbiological diagnostic method. The value of mNGS in patients with FN remains to be studied, especially after empiric antibiotic treatment. METHODS: We retrospectively analyzed the differences between mNGS and the traditional methods in 192 patients with hematological malignancies who have received empiric antibiotic treatment. Samples were collected when patient had chills or half an hour before peak body temperature. And we compared the differences between FN and non-FN patients, mainly including types of pathogens and the diagnostic value of different pathogens. RESULTS: Despite receiving empirical treatment, the pathogen detection rate of mNGS was significantly higher than the traditional method (80.21% vs 25.00%, P<0.001). And it has obvious advantages in detecting mixed pathogens infection (80.21% vs 4.17%, P<0.001). Then, we found that mNGS saw more pathogens in the FN than in the non-FN group, especially fungus. 21/33 (63.63%) of FN patients was diagnosed with fungal infections. The fungal detection rate in FN was significantly higher than non-FN group (32.35% vs 12.22%, P=0.001). Besides, the sensitivity of mNGS was higher than the traditional methods in both FN and non-FN group (P<0.001), but no significant difference in specificity (P>0.05). In the FN group, empiric antibiotic treatment of 46/102 (45.10%) patients did not treat all the pathogens detected by mNGS. After adjusting the antimicrobial regimen according to the results of mNGS, the effective rate at 72 hours and 7 days was 22/46 (47.83%) and 24/102 (52.17%), respectively. CONCLUSION: mNGS had a significant impact on the diagnosis of infection and the second-line antimicrobial therapy in FN. mNGS plays a more important role in FN patients, especially in the diagnosis of fungal infections. PURPOSE: Firstly, we compared the difference between mNGS and the traditional methods in the diagnosis of infection. Secondly, we assessed the value of mNGS in FN patients by comparing it with non-FN patients, including types of pathogens and the diagnostic value of different pathogens. In order to show that mNGS plays a more important role in FN. Dove 2022-07-07 /pmc/articles/PMC9273631/ /pubmed/35837537 http://dx.doi.org/10.2147/IDR.S364525 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Meng Wang, Zhao Wang, Jiaxi Lv, Hairong Xiao, Xia Lu, Wenyi Jin, Xin Meng, Juanxia Pu, Yedi Zhao, MingFeng The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title | The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title_full | The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title_fullStr | The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title_full_unstemmed | The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title_short | The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure |
title_sort | value of metagenomic next-generation sequencing in hematological malignancy patients with febrile neutropenia after empiric antibiotic treatment failure |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273631/ https://www.ncbi.nlm.nih.gov/pubmed/35837537 http://dx.doi.org/10.2147/IDR.S364525 |
work_keys_str_mv | AT zhangmeng thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT wangzhao thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT wangjiaxi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT lvhairong thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT xiaoxia thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT luwenyi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT jinxin thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT mengjuanxia thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT puyedi thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT zhaomingfeng thevalueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT zhangmeng valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT wangzhao valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT wangjiaxi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT lvhairong valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT xiaoxia valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT luwenyi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT jinxin valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT mengjuanxia valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT puyedi valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure AT zhaomingfeng valueofmetagenomicnextgenerationsequencinginhematologicalmalignancypatientswithfebrileneutropeniaafterempiricantibiotictreatmentfailure |